What is the ROE (Return on Equity) of Stratec this year?
The ROE of Stratec this year is 0.06 undefined.
Stratec ROE 2024
Stratec ROE
0.06
Stratec Dividend yield
2.33 %
Ticker
SBS.DE
ISIN
DE000STRA555
WKN
STRA55
In 2024, Stratec's return on equity (ROE) was 0.06, a -56.85% increase from the 0.13 ROE in the previous year.
Stratec Aktienanalyse
What does Stratec do?
The company Stratec SE is a German company operating in the medical technology industry. It was founded in 1984 and has since become a leading provider of automation solutions and diagnostic instruments. Stratec's business model is based on the development and production of devices and systems used in medical diagnostics. The company focuses in particular on the areas of immunology, clinical chemistry, and hematology. Stratec also offers innovative solutions in microscopy and cell analysis. In the "automation solutions" division, Stratec develops systems for the automation of laboratory processes. These are mainly used in clinical diagnostics to accelerate and simplify workflow. Examples include sample identification systems, pipetting robots, and analysis devices. In the "in vitro diagnostics" division, Stratec offers products for determining blood values. This includes devices for determining glucose, cholesterol, and hemoglobin levels, as well as devices for infection diagnostics and tumor and allergy diagnostics. Another division of Stratec is "microscopy." The company manufactures automated microscope systems, primarily used in biomedical research to analyze cells and tissues. In the "cell analysis" division, Stratec offers innovative methods for analyzing cells, such as cell growth and vitality determination. Stratec always focuses on tailoring the design of its products to the needs of its customers. High flexibility in device development and manufacturing is therefore an important factor in the company's success. In addition to device development and production, Stratec also provides services related to its products. These include installation, maintenance, and on-site repair of devices for customers. Stratec SE operates internationally and has branches in Europe, Asia, and America. The company employs over 1,000 people worldwide. Overall, Stratec SE is a successful and renowned provider of medical devices and systems for automating laboratory processes. With its diverse product portfolio and high flexibility in customer support, Stratec has earned a leading position in the industry. Stratec ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding Stratec's Return on Equity (ROE)
Stratec's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing Stratec's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
Stratec's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in Stratec’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about Stratec Stock
How has the Return on Equity (ROE) of Stratec developed compared to the previous year?
The ROE of Stratec has increased by -56.85% decreased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of Stratec?
A high ROE indicates that Stratec generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of Stratec?
A low ROE can indicate that Stratec is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of Stratec affect the company?
A change in ROE (Return on Equity) of Stratec can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of Stratec?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of Stratec?
Some factors that can influence Stratec's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does Stratec pay?
Over the past 12 months, Stratec paid a dividend of 0.97 EUR . This corresponds to a dividend yield of about 2.33 %. For the coming 12 months, Stratec is expected to pay a dividend of 1.05 EUR.
What is the dividend yield of Stratec?
The current dividend yield of Stratec is 2.33 %.
When does Stratec pay dividends?
Stratec pays a quarterly dividend. This is distributed in the months of June, June, June, June.
How secure is the dividend of Stratec?
Stratec paid dividends every year for the past 0 years.
What is the dividend of Stratec?
For the upcoming 12 months, dividends amounting to 1.05 EUR are expected. This corresponds to a dividend yield of 2.52 %.
In which sector is Stratec located?
Stratec is assigned to the 'Health' sector.
Wann musste ich die Aktien von Stratec kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Stratec from 5/22/2024 amounting to 0.55 EUR, you needed to have the stock in your portfolio before the ex-date on 5/20/2024.
When did Stratec pay the last dividend?
The last dividend was paid out on 5/22/2024.
What was the dividend of Stratec in the year 2023?
In the year 2023, Stratec distributed 0.95 EUR as dividends.
In which currency does Stratec pay out the dividend?
The dividends of Stratec are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Stratec stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Stratec
Our stock analysis for Stratec Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Stratec Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
